Journals / Turkish Journal of Gastroenterology / 2016 / Cilt: 27 - Sayı: 2

Incidence rate of anemia in inflammatory bowel diseases

Pages
143–148
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: This is the first study to report the incidence rate of anemia (103.45 per 1,000 patient-years) in a longterm cohort of IBD patients

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/Aims: To determine the incidence rate and distribution of anemia types over time from an Inflammatory Bowel Disease (IBD) patient cohort spanning 18 years.
📊
Key Findings & Data:Materials and Methods: Between January 1995 and November 2013, the University Hospital digital databases as well as hard copies of patients' files were reviewed retrospectively.
💡
Conclusion & Impact:Conclusion: This is the first study to report the incidence rate of anemia (103.45 per 1,000 patient-years) in a longterm cohort of IBD patients
🔬Design:Review & Systematic Survey
📍Scope:2013 Verileri
⚙️Variables:Domain Parameters

Özet

Background/Aims: To determine the incidence rate and distribution of anemia types over time from an Inflammatory Bowel Disease (IBD) patient cohort spanning 18 years. Materials and Methods: Between January 1995 and November 2013, the University Hospital digital databases as well as hard copies of patients' files were reviewed retrospectively. IBD patients with at least one complete blood count (CBC) report were included in this study. Results: We obtained 941 IBD patients' records; 375 (39.9%) patients were diagnosed with Crohn's disease (CD), and 566 (60.1%) patients had ulcerative colitis (UC). Anemia was detected in 548 (58.2%) patients. Female patients were more frequently anemic than male patients (68.4% vs. 49.7%, p=0.001). The frequency of anemia was slightly higher in patients with CD (62.1%) than in patients with UC (55.7%) (p=0.04). The incidence rate of anemia for the entire IBD patient cohort was calculated as 103.45 per 1,000 patient-years. The correlation between the age of the IBD disease and the presence of anemia exhibited a high correlation coefficient of Pearson's r=0.702. Conclusion: This is the first study to report the incidence rate of anemia (103.45 per 1,000 patient-years) in a longterm cohort of IBD patients

🔖

Cite This Article

ATUĞ, Ö., KANİ, H. T., İMERYÜZ, N., AKIN, H. (2016). Incidence rate of anemia in inflammatory bowel diseases. Turkish Journal of Gastroenterology, Cilt: 27 - Sayı: 2, 143–148. https://ajindex.com/articles/409353

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med 2009; 361: 2066-78. [CrossRef] Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002; 347: 417-29. [CrossRef] Pizzi LT, Weston CM, Goldfarb NI, et al. Impact of chronic condi- tions on quality of life in patients with inflammatory bowel dis- ease. Inflamm Bowel Dis 2006; 12: 47-52. [CrossRef] Wells CW, Lewis S, Barton JR, Corbett S. Effects of changes in he- moglobin level on quality of life and cognitive function in inflam- matory bowel disease patients. Inflamm Bowel Dis 2006; 12: 123- 30. [CrossRef] Gomollon F, Gisbert JP. Anemia and inflammatory bowel diseases. World J Gastroenterol 2009; 15: 4659-65. [CrossRef] Reinisch W, Staun M, Bhandari S, Munoz M. State of the iron: how to diagnose and efficiently treat iron deficiency anemia in inflamma- tory bowel disease. J Crohns Colitis 2013; 7: 429-40. [CrossRef] de Silva AD, Mylonaki M, Rampton DS. Oral iron therapy in inflam- matory bowel disease: usage, tolerance, and efficacy. Inflamm Bowel Dis 2003; 9: 316-20. [CrossRef] Kulnigg S, Gasche C. Systematic review: managing anaemia in Crohn's disease. Aliment Pharmacol Ther 2006; 24: 1507-23. [CrossRef] Wilson A, Reyes E, Ofman J. Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the litera- ture. Am J Med 2004; 116(Suppl 7A): 44s-9s. [CrossRef] Nikolaus S, Schreiber S. Diagnostics of inflammatory bowel dis- ease. Gastroenterology 2007; 133: 1670-89. [CrossRef] Dignass AU, Gasche C, Bettenworth D, et al. European consensus on the diagnosis and management of iron deficiency and anae- mia in inflammatory bowel diseases. J Crohns Colitis 2015; 9: 211- 22. [CrossRef] UNICEF, UNU, WHO, MO, Technical, Workshop. Preventing iron deficiency in womenand children: background and consensus on key technical issuesand resources for advocacy. Planning and Implementing National Programmes. Tozun N, Atug O, Imeryuz N, et al. Clinical characteristics of in- flammatory bowel disease in Turkey: a multicenter epidemiologic survey. J Clin Gastroenterol 2009; 43: 51-7. [CrossRef] Filmann N, Rey J, Schneeweiss S, et al. Prevalence of anemia in inflammatory bowel diseases in european countries: a systematic review and individual patient data meta-analysis. Inflamm Bowel Dis 2014; 20: 936-45. [CrossRef] Last JM, Spasoff RA, International Epidemiological Association. A dictionary of epidemiology. 4th ed. Oxford: Oxford University Press; 2001.
  2. Bager P, Befrits R, Wikman O, L et al. T